Stock Research for VRTHF

VRTHF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

VRTHF Stock Chart & Research Data

The VRTHF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VRTHF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


VRTHF Due diligence Resources & Stock Charts

The VRTHF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View VRTHF Detailed Price Forecast - CNN Money CNN View VRTHF Detailed Summary - Google Finance
Yahoo View VRTHF Detailed Summary - Yahoo! Finance Zacks View VRTHF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View VRTHF Trends & Analysis - Trade-Ideas Barrons View VRTHF Major Holders - Barrons
NASDAQ View VRTHF Call Transcripts - NASDAQ Seeking View VRTHF Breaking News & Analysis - Seeking Alpha
Spotlight View VRTHF Annual Report - CompanySpotlight.com OTC Report View VRTHF OTC Short Report - OTCShortReport.com
TradeKing View VRTHF Fundamentals - TradeKing Charts View VRTHF SEC Filings - Bar Chart
WSJ View Historical Prices for VRTHF - The WSJ Morningstar View Performance/Total Return for VRTHF - Morningstar
MarketWatch View the Analyst Estimates for VRTHF - MarketWatch CNBC View the Earnings History for VRTHF - CNBC
StockMarketWatch View the VRTHF Earnings - StockMarketWatch MacroAxis View VRTHF Buy or Sell Recommendations - MacroAxis
Bullish View the VRTHF Bullish Patterns - American Bulls Short Pains View VRTHF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View VRTHF Stock Mentions - StockTwits PennyStocks View VRTHF Stock Mentions - PennyStockTweets
Twitter View VRTHF Stock Mentions - Twitter Invest Hub View VRTHF Investment Forum News - Investor Hub
Yahoo View VRTHF Stock Mentions - Yahoo! Message Board Seeking Alpha View VRTHF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for VRTHF - SECform4.com Insider Cow View Insider Transactions for VRTHF - Insider Cow
CNBC View VRTHF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for VRTHF - OTC Markets
Yahoo View Insider Transactions for VRTHF - Yahoo! Finance NASDAQ View Institutional Holdings for VRTHF - NASDAQ


Stock Charts

FinViz View VRTHF Stock Insight & Charts - FinViz.com StockCharts View VRTHF Investment Charts - StockCharts.com
BarChart View VRTHF Stock Overview & Charts - BarChart Trading View View VRTHF User Generated Charts - Trading View




Latest Financial News for VRTHF


Veritas Pharma to Commence Legal Proceedings Against Liht Cannabis
Posted on Monday March 04, 2019

VANCOUVER, British Columbia, March 04, 2019 -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has filed a claim.


Veritas Enrolls First Patient in Clinical Study to Assess Pain Control with Lead Product
Posted on Friday February 22, 2019

CTL-X, supplied by one of Puerto Rico’s notable cannabis performers, the Institute for Medical Cannabis (“IMC”), will be evaluated on its analgesic properties on simulated pain using standardized pain scales. The clinical research organization, Fundación de Investigación (“FDI”), administered the trial drug in the phase II-III unit at their state-of-the-art facility.


Veritas Pharma Enters into agreement to acquire Commercial Hemp and Cannabis Processing Facility
Posted on Tuesday February 12, 2019

Veritas’ director, Nick Standish, commented, “this is an exciting development for Veritas as it further develops our ability to commercialize our proprietary hemp and cannabis products, in addition to expanding our production potential to topical creams and edibles along with oil extracts.


Veritas Pharma Announces the Resignation of CEO, Dr. Lui Franciosi
Posted on Monday February 11, 2019

Dr. Franciosi stated, “It has been a challenging year with the regulatory delays in starting the Puerto Rico human study of CTL-X and the need to raise funds for medical cannabis research.  I am pleased to see the study approval has finally come through and that potential funding for Cannevert’s important scientific work has been secured, which means that the Veritas and Cannevert are now set for growth under new leadership. Mr. McFadden stated, “The Veritas Board would like to thank Lui for his commitment to investors and to advancing the science behind medical cannabis.”  Dr. Franciosi will continue to assist both companies in an operational capacity.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.